NCT00678834View on ClinicalTrials.gov

Human Tissue Distribution of Orally Supplemented Natural Vitamin E Tocotrienol

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

March 31, 2006

Primary Completion Date

June 30, 2012

Study Completion Date

June 30, 2012

Conditions
End Stage Cardiac FailurePulmonary FailureEnd Stage Liver DiseaseMorbid ObesityRecalcitrant Epilepsy Requiring SurgeryHealthy Subjects
Interventions
DIETARY_SUPPLEMENT

To surgery patients, Tocopherol capsules.

200mg (2 100mg capsules) to take by mouth twice daily to total 400mg daily

DIETARY_SUPPLEMENT

Tocotrienol to healthy subjects.

200 mg to take orally two times a day (400 mg a day).

DIETARY_SUPPLEMENT

To surgery patients, Tocotrienol capsules.

200mg (2 100mg capsules) to take by mouth twice daily to total 400mg daily

Trial Locations (1)

43211

The Ohio State University, Columbus

All Listed Sponsors
collaborator

Carotech Inc.

INDUSTRY

lead

Chandan K Sen

OTHER

NCT00678834 - Human Tissue Distribution of Orally Supplemented Natural Vitamin E Tocotrienol | Biotech Hunter | Biotech Hunter